These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 7682958)
1. Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1). Yamamoto AM; Cresteil D; Boniface O; Clerc FF; Alvarez F Eur J Immunol; 1993 May; 23(5):1105-11. PubMed ID: 7682958 [TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes. Yamamoto AM; Mura C; De Lemos-Chiarandini C; Krishnamoorthy R; Alvarez F Clin Exp Immunol; 1993 Jun; 92(3):381-90. PubMed ID: 7685669 [TBL] [Abstract][Full Text] [Related]
3. Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera. Yamamoto AM; Cresteil D; Homberg JC; Alvarez F Gastroenterology; 1993 Jun; 104(6):1762-7. PubMed ID: 7684716 [TBL] [Abstract][Full Text] [Related]
4. Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients. Kitazawa E; Igarashi T; Kawaguchi N; Matsushima H; Kawashima Y; Hankins RW; Miyakawa H J Autoimmun; 2001 Nov; 17(3):243-9. PubMed ID: 11712862 [TBL] [Abstract][Full Text] [Related]
5. Conformational epitopes on CYP2D6 are recognized by liver/kidney microsomal antibodies. Duclos-Vallée JC; Hajoui O; Yamamoto AM; Jacz-Aigrain E; Alvarez F Gastroenterology; 1995 Feb; 108(2):470-6. PubMed ID: 7530671 [TBL] [Abstract][Full Text] [Related]
6. Sera of children with hepatitis C infection and anti-liver-kidney microsome-1 antibodies recognize different CYP2D6 epitopes than adults with LKM+/HCV+ sera. Herzog D; Yamamoto AM; Jara P; Maggiore G; Sarles J; Alvarez F J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):551-5. PubMed ID: 10554122 [TBL] [Abstract][Full Text] [Related]
7. LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry? Marceau G; Lapierre P; Béland K; Soudeyns H; Alvarez F Hepatology; 2005 Sep; 42(3):675-82. PubMed ID: 16037945 [TBL] [Abstract][Full Text] [Related]
8. Study of the B cell response to cytochrome P450IID6 in sera from chronic hepatitis C patients. Parez N; Herzog D; Jacqz-Aigrain E; Homberg JC; Alvarez F Clin Exp Immunol; 1996 Nov; 106(2):336-43. PubMed ID: 8918582 [TBL] [Abstract][Full Text] [Related]
9. Epitope mapping studies with human anti-cytochrome P450 3A antibodies. Leeder JS; Gaedigk A; Lu X; Cook VA Mol Pharmacol; 1996 Feb; 49(2):234-43. PubMed ID: 8632755 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Muratori L; Lenzi M; Ma Y; Cataleta M; Mieli-Vergani G; Vergani D; Bianchi FB Gut; 1995 Sep; 37(3):406-12. PubMed ID: 7590439 [TBL] [Abstract][Full Text] [Related]
11. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen. Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984 [TBL] [Abstract][Full Text] [Related]
12. Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection. Béland K; Lapierre P; Marceau G; Alvarez F J Autoimmun; 2004 Mar; 22(2):159-66. PubMed ID: 14987745 [TBL] [Abstract][Full Text] [Related]
13. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Ma Y; Bogdanos DP; Hussain MJ; Underhill J; Bansal S; Longhi MS; Cheeseman P; Mieli-Vergani G; Vergani D Gastroenterology; 2006 Mar; 130(3):868-82. PubMed ID: 16530525 [TBL] [Abstract][Full Text] [Related]
14. Antipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6. Cribb A; Nuss C; Wang R Drug Metab Dispos; 1995 Jul; 23(7):671-5. PubMed ID: 7587952 [TBL] [Abstract][Full Text] [Related]
15. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483 [TBL] [Abstract][Full Text] [Related]
16. A human cytochrome P-450 is recognized by anti-liver/kidney microsome antibodies in autoimmune chronic hepatitis. Kiffel L; Loeper J; Homberg JC; Leroux JP Biochem Biophys Res Commun; 1989 Feb; 159(1):283-9. PubMed ID: 2466461 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the B cell response of patients with anti-liver cytosol autoantibodies in type 2 autoimmune hepatitis. Lapierre P; Johanet C; Alvarez F Eur J Immunol; 2003 Jul; 33(7):1869-78. PubMed ID: 12811847 [TBL] [Abstract][Full Text] [Related]
18. Antipeptide antibodies targeted against specific regions of rat CYP2D1 and human CYP2D6. Laurenzana EM; Sorrels SL; Owens SM Drug Metab Dispos; 1995 Feb; 23(2):271-8. PubMed ID: 7736924 [TBL] [Abstract][Full Text] [Related]
19. Localization and fine mapping of antigenic sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome virus with monoclonal antibodies. Meulenberg JJ; van Nieuwstadt AP; van Essen-Zandbergen A; Bos-de Ruijter JN; Langeveld JP; Meloen RH Virology; 1998 Dec; 252(1):106-14. PubMed ID: 9875321 [TBL] [Abstract][Full Text] [Related]
20. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. Manns MP; Johnson EF; Griffin KJ; Tan EM; Sullivan KF J Clin Invest; 1989 Mar; 83(3):1066-72. PubMed ID: 2466049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]